2019年2月18日星期一

ADVANTAGES OF VASOACTIVE INTESTINAL PEPTIDE FOR THE FUTURE TREATMENT OF PARKINSON'S DISEASE.

ADVANTAGES OF VASOACTIVE INTESTINAL PEPTIDE FOR THE FUTURE TREATMENT OF PARKINSON'S DISEASE.

OT KorkmazN Tunçel - Current pharmaceutical design, 2019 - europepmc.org
Parkinson's disease is the second most common neurodegenerative disorder in adults over
the age of 65. The characteristic symptoms of Parkinson's disease, such as resting tremor,
muscular rigidity, bradykinesia, postural instability and gait imbalance, are thought to be a …


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论